Healthcare

Global Cell & Gene Therapy Quality Control and Analytics Market Set to Surpass New Milestones with AI-Driven Growth Through 2034

Healthcare
/

The cell and gene therapy quality control and analytics market stands at the forefront of the next healthcare revolution. Growing at a remarkable compound annual growth rate (CAGR), with Asia Pacific leading at approximately 33.5%, this sector is driven by surging cases of genetic diseases, relentless innovation in gene editing, and real-time, AI-enabled analytics. North […]

Cell Encapsulation Technology Market to Reach New Heights by 2034 with Robust Growth and Innovation

Healthcare
/ /

The global cell encapsulation technology market is projected to grow significantly, driven by advances in biocompatible materials, immunoprotective systems, and AI-enabled research. Valued strongly today, the market is forecasted to expand over the next decade, fueled by rising demand for immune-protected cell therapies in treating chronic diseases such as diabetes and neurodegenerative conditions. Introduction: Accelerating

In Vivo Cell Reprogramming Market to Reach Significant Valuation by 2034 with Rapid Growth Driven by Regenerative Medicine Innovations

Healthcare
/ /

The global in vivo cell reprogramming market is poised for substantial expansion, projected to witness strong growth with a CAGR reflecting increasing clinical applications in tissue repair and regenerative therapies. This transformative market revolves around reprogramming somatic cells directly within the body to restore organ function and treat complex diseases, redefining therapeutic approaches across cardiac,

Engineered TCR (T-Cell Receptor) Therapy Market Poised for Explosive Growth, to Reach Significant Valuation by 2034

Healthcare
/

Revolutionizing cancer treatment with targeted immunotherapy, the engineered TCR therapy market is forecast to grow rapidly at a robust CAGR driven by technological innovations and expanded clinical applications. The global engineered TCR (T-cell receptor) therapy market is rapidly advancing, riding a wave of increasing cancer incidence, especially solid tumors, and breakthroughs in immunotherapy. Expected to

Bioinformatics-as-a-Service Market Size to Surpass USD 14.56 Billion by 2034

Healthcare
/ /

The global Bioinformatics-as-a-Service (BaaS) market achieved a milestone value of USD 3.75 billion in 2024 and is forecast to rocket to nearly USD 14.56 billion by 2034, expanding at a compound annual growth rate (CAGR) of 14.53% across the forecast period. This surge is fueled by the proliferation of genomics, the rising adoption of precision

Foley Catheters Market Size to Reach USD 3.33 Billion by 2034 Driven by Rising Urological Disorders and Aging Population

Healthcare
/ /

The global Foley catheters market size was valued at USD 1.87 billion in 2024 and is projected to grow to approximately USD 3.33 billion by 2034, exhibiting a robust compound annual growth rate (CAGR) of 5.94% from 2025 to 2034. This growth is propelled by increasing prevalence of urological disorders, an expanding geriatric population, and

Estrogen Replacement Therapy Market: Key Companies & Their Strategic Landscape

Companies, Healthcare
/ / ,

Estrogen Replacement Therapy Market Companies Pfizer Inc. Bayer AG Novartis AG Merck & Co., Inc. Abbott Laboratories Novo Nordisk A/S Eli Lilly and Company Teva Pharmaceutical Industries Ltd. Mylan N.V. (Viatris Inc.) Endo International plc. TherapeuticsMD, Inc. Allergan plc. (AbbVie Inc.) Amgen Inc. Ipsen Biopharmaceuticals Orion Pharma Ferring Pharmaceuticals Aspen Pharmacare Holdings Limited Sun Pharmaceutical

Next Generation Pulse Oximeters Market Track AI-powered wearables and telehealth-driven home monitoring adoption

Healthcare
/ /

Advanced Monitoring Tech to Transform Home Healthcare and Digital Wellness Globally The global next generation pulse oximeters market is expected to reach unprecedented heights between 2025 and 2034, driven by an expanding focus on telemedicine, preventive care, and digital health ecosystems. With a robust CAGR forecast and North America claiming the top spot for innovation,

Leading Neurological Rare Disease Biologics Market Companies: A Detailed Profile

Companies, Healthcare
/ / ,

Neurological Rare Disease Biologics Market Companies Alexion (AstraZeneca) Amgen Biogen Bluebird bio Catalent Eli Lilly Ionis Pharmaceuticals Novartis Pfizer Regenxbio Roche / Genentech Sanofi Sarepta Therapeutics Stoke Therapeutics UCB Get Sample Report 1. Alexion (AstraZeneca) Company Name and Headquarters: Alexion Pharmaceuticals, Inc. (an AstraZeneca Company), headquartered in Boston, Massachusetts, USA. Product Offerings related to Neurological Rare Disease

Scroll to Top